Alphabet Class A
Broadcom is joining Alphabet in the AI rally. Why investors are jumping in
A Broadcom circuit board for chip testing is pictured during a lab tour as Broadcom prepares to launch new optical chip tech to fend off Nvidia in San Jose, California, U.S., September 5, 2025. Brittany Hosea-small | Reuters Broadcom shares rallied 11.1% on Monday, as investors poured back into several high-flying tech companies tied to […]
Read More
Anthropic unveils Claude Opus 4.5, its latest AI model following $350 billion valuation
Dario Amodei, co-founder and CEO of artificial intelligence startup Anthropic. Chesnot | Getty Images Anthropic on Monday announced Claude Opus 4.5, its latest artificial intelligence model that the startup says excels at coding, using computers and assisting users with complex enterprise tasks. Claude Opus 4.5 marks Anthropic’s third major model launch in two months, and […]
Read More
Stocks making the biggest moves midday: Novo Nordisk, Inspire Medical, Tesla, Tegna, Oscar Health and more
Check out the companies making the biggest moves midday: Novo Nordisk — The Danish pharmaceutical company’s trial for Alzheimer’s disease failed to meet its main goal of slowing the disease’s progression. Shares tumbled nearly 6%. Inspire Medical Systems — The maker of an obstructive sleep apnea treatment will benefit from Friday’s decision by the Centers […]
Read More
Alphabet is surging on notion it’s winning AI race over OpenAI. Why that’s scaring many investors
Alphabet ‘s recent move into the spotlight on artificial intelligence has sent its shares jumping while other major technology names flounder. Shares of the Google parent surged more than 5% on Monday, adding to last week’s gain of more than 8%. The Big Tech stock is on track to finish November higher by more than […]
Read More
Stocks making the biggest moves premarket: Novo Nordisk, Tesla, Alphabet, Oscar Health & more
Check out the companies making the biggest moves in premarket trading: Novo Nordisk — Shares tumbled 10% after the Danish pharmaceutical company’s trial for Alzheimer’s disease failed to meet its main goal of slowing the disease’s progression. Tesla — CEO Elon Musk said on X that the company is close to finalizing its latest artificial-intelligence […]
Read More
CNBC Daily Open: A turnaround in sentiment for U.S. markets may be in the cards
Traders work on the floor of the New York Stock Exchange (NYSE) on Nov. 21, 2025 in New York City. Spencer Platt | Getty Images Last week on Wall Street, two forces dragged stocks lower: a set of high-stakes numbers from Nvidia and the U.S. jobs report that landed with more heat than expected. But […]
Read More